30588060|t|Adult-onset type II citrullinemia: Current insights and therapy.
30588060|a|Citrin deficiency is a recessively inherited metabolic disorder with age-dependent clinical manifestations. It causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2). Patients with NICCD present with intrahepatic cholestasis in the neonatal period and usually respond to the treatment with medium-chain triglyceride (MCT) supplement and lactose-restricted formula. In adulthood, CTLN2 develops in <10 % of the patients showing hyperammonemic encephalopathy. Patients with CTLN2 required liver transplantation for the most promising prognosis; however, they were successfully treated with MCT supplement with a low carbohydrate formula. Citrin deficiency is caused by mutations in SLC25A13 on chromosome 7q21.3, with a high frequency in East Asia, including Japan. Citrin is aspartate/glutamate transporter in mitochondria, a component of malate-aspartate nicotinamide adenine dinucleotide hydrogen shuttle, and is essential for the hepatic glycolysis. Although the precise pathophysiology of citrin deficiency remains unclear, recent reports for the effective MCT supplement therapy and downregulation of peroxisome proliferator-activated receptor alpha suggest that citrin deficiency impairs hepatic de novo lipogenesis coupled with glycolysis leading to the energy deficit of hepatocytes. Herein, we review the current therapeutic and pathological understanding of CTLN2.
30588060	0	33	Adult-onset type II citrullinemia	Disease	MESH:C538053
30588060	65	82	Citrin deficiency	Disease	MESH:C538053
30588060	110	128	metabolic disorder	Disease	MESH:D008659
30588060	183	216	neonatal intrahepatic cholestasis	Disease	MESH:D002780
30588060	218	223	NICCD	Disease	MESH:C536398
30588060	229	262	adult-onset type II citrullinemia	Disease	MESH:C538053
30588060	264	269	CTLN2	Gene	10165
30588060	272	280	Patients	Species	9606
30588060	286	291	NICCD	Disease	MESH:C536398
30588060	305	329	intrahepatic cholestasis	Disease	MESH:D002780
30588060	395	420	medium-chain triglyceride	Chemical	MESH:C000709826
30588060	422	425	MCT	Chemical	MESH:C000709826
30588060	442	449	lactose	Chemical	MESH:D007785
30588060	484	489	CTLN2	Gene	10165
30588060	515	523	patients	Species	9606
30588060	532	561	hyperammonemic encephalopathy	Disease	MESH:D001927
30588060	563	571	Patients	Species	9606
30588060	577	582	CTLN2	Gene	10165
30588060	693	696	MCT	Chemical	MESH:C000709826
30588060	719	731	carbohydrate	Chemical	MESH:D002241
30588060	741	758	Citrin deficiency	Disease	MESH:C538053
30588060	785	793	SLC25A13	Gene	10165
30588060	797	814	chromosome 7q21.3	Chromosome	7
30588060	869	875	Citrin	Gene	10165
30588060	943	949	malate	Chemical	MESH:C030298
30588060	960	993	nicotinamide adenine dinucleotide	Chemical	MESH:D009243
30588060	994	1002	hydrogen	Chemical	MESH:D006859
30588060	1097	1114	citrin deficiency	Disease	MESH:C538053
30588060	1165	1168	MCT	Chemical	MESH:C000709826
30588060	1210	1258	peroxisome proliferator-activated receptor alpha	Gene	5465
30588060	1272	1289	citrin deficiency	Disease	MESH:C538053
30588060	1472	1477	CTLN2	Gene	10165
30588060	Association	MESH:D001927	10165
30588060	Negative_Correlation	MESH:C000709826	10165
30588060	Positive_Correlation	MESH:C538053	10165
30588060	Association	MESH:D007785	MESH:C538053
30588060	Negative_Correlation	MESH:D007785	MESH:D002780
30588060	Negative_Correlation	MESH:C000709826	MESH:D002780
30588060	Negative_Correlation	MESH:D007785	MESH:C536398
30588060	Negative_Correlation	MESH:C000709826	MESH:C536398
30588060	Association	MESH:C538053	5465
30588060	Negative_Correlation	MESH:C000709826	MESH:C538053

